Latest News - Boston Scientific
Top Corporates Hub
Boston Scientific
Boston Scientific (BSX) Receives FDA Clearance for Asurys Fluid Management System
10.04.2026 05:03
Boston Scientific Corporation (NYSE:BSX) is one of the 10 Best Growth Stocks to Buy for the Next Decade. Boston Scientific Corporation (NYSE:BSX) is one of the best growth stocks to buy for the next decade. On March 30, Boston Scientific received FDA 510(k) clearance for its Asurys Fluid Management System, a new technology designed to […]
Penumbra Sale To Boston Scientific Sparks Review Of Deal Value
10.04.2026 03:12
Boston Scientific has entered into a definitive agreement to acquire Penumbra (NYSE:PEN). A law firm has announced an investigation into whether the sale process and terms of the transaction are fair to Penumbra shareholders. The deal and the legal review arrive at a time when Penumbra’s share price stands at $329.52. For investors following NYSE:PEN, the agreed sale to Boston Scientific comes after a period of solid longer term returns, including 22.7% over the past year and 19.0% over...
CIRCA Scientific Appoints MedTech Executive Vafa Jamali to Board of Directors
09.04.2026 14:00
CIRCA Scientific today announced the appointment of Vafa Jamali, an accomplished medical technology executive with more than 30 years of industry leadership experience, to its Board of Directors.
Is It Time To Revisit Boston Scientific (BSX) After This Year’s Sharp Share Price Pullback
08.04.2026 03:11
Investors may be wondering if Boston Scientific at around US$61.86 is starting to look attractive, or if the recent pullback is hinting at deeper valuation questions. The stock is down about 1.4% over the last week, 13.3% over the last month, and 34.7% year to date, with a 31.8% decline over 1 year, while the 3 and 5 year returns sit at 21.9% and 57.0% respectively. These moves are set against a backdrop of ongoing attention on Boston Scientific's role in the medical device space and how...
Boston Scientific Corp (NYSE:BSX) Offers Affordable Growth for Value-Conscious Investors
07.04.2026 08:11
Boston Scientific (BSX) exemplifies affordable growth investing, offering strong double-digit expansion at a reasonable valuation backed by high profitability.
Boston Scientific's 2026 Guidance 'Reasonable', RBC Says
02.04.2026 14:57
Boston Scientific's (BSX) 2026 guidance is "reasonable", but stock sentiment is being driven by the
Boston Scientific (BSX) Says CHAMPION-AF Trial Meets All Primary Endpoints
01.04.2026 11:40
Boston Scientific Corporation (NYSE:BSX) is one of the 10 Best 52-Week Low NYSE Stocks to Buy Now. On March 29, 2026, Boston Scientific Corporation (NYSE:BSX) announced that its CHAMPION-AF clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated the WATCHMAN FLX device versus NOACs for stroke risk reduction in patients […]
Boston Scientific: From Hypergrowth To Durable Compounding
01.04.2026 04:43
Boston Scientific (BSX) is down 35% but still growing fast with strong marginsâsee valuation, key catalysts (WATCHMAN, EP, M&A), and risks.
Boston Scientific (BSX) Stock Trades Down, Here Is Why
31.03.2026 02:06
Shares of medical device company Boston Scientific (NYSE:BSX) fell 9.4% in the afternoon session after Raymond James downgraded the stock to Outperform from Strong Buy, citing worries about the company's growth prospects. The firm lowered its price target and estimates to reflect slower trends in Boston Scientific's key growth areas, specifically U.S. electrophysiology and its Watchman device.
Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo - Slideshow
29.03.2026 13:00
2026-03-29. The following slide deck was published by Boston Scientific Corporation in conjunction with this event.
Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript
29.03.2026 00:45
Boston Scientific Corporation (BSX) American College of Cardiology 75th Annual Scientific Session and Expo March 28, 2026 6:30 PM EDTCompany...
Boston Scientific Unveils “Practice-Transforming” Trial Data for PE and AF at ACC Conference Call
29.03.2026 00:04
Boston Scientific (NYSE:BSX) executives highlighted new data from two randomized clinical trials during an American College of Cardiology conference call, describing the results as potentially “practice transforming” for pulmonary embolism (PE) and stroke prevention in atrial fibrillation (AF). The
What Moved Markets This Week
28.03.2026 06:44
U.S. stocks ended lower on the week as elevated U.S.-Iran tensions remained in focus. Read more about this week's major events on Wall Street.
Why The Narrative Around Boston Scientific (BSX) Is Shifting As Analysts Reset Expectations
26.03.2026 10:03
Boston Scientific’s fair value estimate has been adjusted from US$104.24 to US$102.00, a modest trim that lines up with the recent wave of price target resets across the Street. Analysts are not making sweeping calls on the business model; instead, they are tightening their assumptions on growth and execution, which feeds directly into where those targets land. As you read on, you will see how these shifting targets and research themes can help you track the evolving story around the...
Boston Scientific: Under Pressure, But Could See A Shift In Fortunes (Rating Upgrade)
25.03.2026 02:50
Amidst the ongoing pressure, we are now upgrading Boston Scientific stock from hold to buy. Click here to read why.
Is Boston Scientific (BSX) Still Attractive After Its Recent Share Price Pullback?
22.03.2026 03:09
If you are wondering whether Boston Scientific's current share price still reflects its long term potential, the recent moves in the stock give you plenty to think about. The shares last closed at US$69.48, with returns of 0.5% over 7 days, a 6.8% decline over 30 days, a 26.6% decline year to date, and a 31.0% decline over 1 year, set against gains of 44.1% over 3 years and 81.8% over 5 years. These mixed returns have kept attention on how the market is weighing Boston Scientific's growth...
Truist Cuts PT on Boston Scientific Corporation (BSX) to $92 From $95 – Here’s Why
21.03.2026 10:29
Boston Scientific Corporation (NYSE:BSX) is one of the best long term stocks to invest in according to billionaires. Truist cut the price target on Boston Scientific Corporation (NYSE:BSX) to $92 from $95 on March 18, reiterating a Buy rating on the shares. The rating update came ahead of the company’s CHAMPION-AF readout, with the firm […]
Needham Reiterates Buy on Boston Scientific, Maintains $97 Price Target
20.03.2026 06:25
Needham analyst Mike Matson reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $97 price target.
Sacral neuromodulation: broadening Boston Scientific’s European urology portfolio
18.03.2026 12:39
Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.